Pub Date : 2020-01-01DOI: 10.35248/2167-0889.20.9.240
S. Thasneem, Yedu Krishnan Ss, Roshni Pr, S. Sadasivan
Frailty is an unstable phenomenon affecting multiple physiological systems, resulting in decreased reserve and vulnerable outcomes. With ageing the prevalence of frailty seems to be increasing general population as well as with cirrhosis patients. Though research are undergoing on prognostic markers, gut microbes or pharmacology in hepatology, it should be extended to a proper definition for frailty its diagnostic tool and management. Frailty score should be considered along with MELD score as a routine assessment in patients waiting for liver transplantation. Malnutrition is a common complication of cirrhosis patients which may leads to frailty, even though frailty is seen in well-nourished patients. When normal dietary supplements become ineffective the need for nutritional supplements like Branched chain amino acids (BCAA) become necessary. Combining BCAAs along with exercise therapy have shown significant improvements for lower limb muscle strength and balance ability in frail and pre-frail cirrhotic patients since muscle wasting is a major concern for them.
{"title":"A Review on Frailty in Patient with Liver Cirrhosis and Its Management","authors":"S. Thasneem, Yedu Krishnan Ss, Roshni Pr, S. Sadasivan","doi":"10.35248/2167-0889.20.9.240","DOIUrl":"https://doi.org/10.35248/2167-0889.20.9.240","url":null,"abstract":"Frailty is an unstable phenomenon affecting multiple physiological systems, resulting in decreased reserve and vulnerable outcomes. With ageing the prevalence of frailty seems to be increasing general population as well as with cirrhosis patients. Though research are undergoing on prognostic markers, gut microbes or pharmacology in hepatology, it should be extended to a proper definition for frailty its diagnostic tool and management. Frailty score should be considered along with MELD score as a routine assessment in patients waiting for liver transplantation. Malnutrition is a common complication of cirrhosis patients which may leads to frailty, even though frailty is seen in well-nourished patients. When normal dietary supplements become ineffective the need for nutritional supplements like Branched chain amino acids (BCAA) become necessary. Combining BCAAs along with exercise therapy have shown significant improvements for lower limb muscle strength and balance ability in frail and pre-frail cirrhotic patients since muscle wasting is a major concern for them.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"136 1","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76738273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.35248/2167-0889.20.9.E118
Min Li
Clinical hepatology has recently gained a wider recognition among medical community owing to the advancements in liver biochemical investigations and with liver diseases now being increasingly recognized as a major threat to public health. Malnutrition, drug addiction, alcohol abuse and environmental pollution are prevalent across different regions of the world which are identified to be associated with risk factors of liver diseases. Liver diseases, if highly prevalent and if remain untreated, may lead to reduced longevity and productivity and can hamper the socioeconomic contribution.
{"title":"Recent and Novel Observations Pertaining to Non-Infectious Liver Disorders","authors":"Min Li","doi":"10.35248/2167-0889.20.9.E118","DOIUrl":"https://doi.org/10.35248/2167-0889.20.9.E118","url":null,"abstract":"Clinical hepatology has recently gained a wider recognition among medical community owing to the advancements in liver biochemical investigations and with liver diseases now being increasingly recognized as a major threat to public health. Malnutrition, drug addiction, alcohol abuse and environmental pollution are prevalent across different regions of the world which are identified to be associated with risk factors of liver diseases. Liver diseases, if highly prevalent and if remain untreated, may lead to reduced longevity and productivity and can hamper the socioeconomic contribution.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"302 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79731113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.35248/2167-0889.20.9.E119
Min Li
{"title":"Editor's Note on Liver Journal","authors":"Min Li","doi":"10.35248/2167-0889.20.9.E119","DOIUrl":"https://doi.org/10.35248/2167-0889.20.9.E119","url":null,"abstract":"","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"1 1","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89677891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-22DOI: 10.35248/2167-0889.19.8.236
Shujing Li, Xicui Sun, Minjie Chen, Z. Ying, Yamin Wan, Liya Pi, Bin Ren, Qi Cao
Liver fibrosis is a serious, life-threatening disease with high morbidity and mortality that result from diverse causes. Liver biopsy, considered the “gold standard” to diagnose, grade, and stage liver fibrosis, has limitations in terms of invasiveness, cost, sampling variability, inter-observer variability, and the dynamic process of fibrosis. Compelling evidence has demonstrated that all stages of fibrosis are reversible if the injury is removed. There is a clear need for safe, effective, and reliable non-invasive assessment modalities to determine liver fibrosis in order to manage it precisely in personalized medicine. However, conventional imaging methods used to assess morphological and structural changes related to liver fibrosis, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), are only useful in assessing advanced liver disease, including cirrhosis. Functional imaging techniques, including MR elastography (MRE), US elastography, and CT perfusion are useful for assessing moderate to advanced liver fibrosis. MRE is considered the most accurate noninvasive imaging technique, and US elastography is currently the most widely used noninvasive means. However, these modalities are less accurate in early-stage liver fibrosis and some factors affect the accuracy of these techniques. Molecular imaging is a target-specific imaging mechanism that has the potential to accurately diagnose early-stage liver fibrosis. We provide an overview of recent advances in molecular imaging for the diagnosis and staging of liver fibrosis which will enable clinicians to monitor the progression of disease and potentially reverse liver fibrosis. We compare the promising technologies with conventional and functional imaging and assess the utility of molecular imaging in precision and personalized clinical medicine in the early stages of liver fibrosis.
{"title":"Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update","authors":"Shujing Li, Xicui Sun, Minjie Chen, Z. Ying, Yamin Wan, Liya Pi, Bin Ren, Qi Cao","doi":"10.35248/2167-0889.19.8.236","DOIUrl":"https://doi.org/10.35248/2167-0889.19.8.236","url":null,"abstract":"Liver fibrosis is a serious, life-threatening disease with high morbidity and mortality that result from diverse causes. Liver biopsy, considered the “gold standard” to diagnose, grade, and stage liver fibrosis, has limitations in terms of invasiveness, cost, sampling variability, inter-observer variability, and the dynamic process of fibrosis. Compelling evidence has demonstrated that all stages of fibrosis are reversible if the injury is removed. There is a clear need for safe, effective, and reliable non-invasive assessment modalities to determine liver fibrosis in order to manage it precisely in personalized medicine. However, conventional imaging methods used to assess morphological and structural changes related to liver fibrosis, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), are only useful in assessing advanced liver disease, including cirrhosis. Functional imaging techniques, including MR elastography (MRE), US elastography, and CT perfusion are useful for assessing moderate to advanced liver fibrosis. MRE is considered the most accurate noninvasive imaging technique, and US elastography is currently the most widely used noninvasive means. However, these modalities are less accurate in early-stage liver fibrosis and some factors affect the accuracy of these techniques. Molecular imaging is a target-specific imaging mechanism that has the potential to accurately diagnose early-stage liver fibrosis. We provide an overview of recent advances in molecular imaging for the diagnosis and staging of liver fibrosis which will enable clinicians to monitor the progression of disease and potentially reverse liver fibrosis. We compare the promising technologies with conventional and functional imaging and assess the utility of molecular imaging in precision and personalized clinical medicine in the early stages of liver fibrosis.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80933885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.4172/2167-0889.1000235
T. Shizuma
Aeromonas species are recognized as opportunistic pathogens that cause serious problems in patients with liver cirrhosis (LC). In this article, 25 case reports of Aeromonas infections in patients with LC in Japan are reviewed and summarized. Among the 25 cases, cases of septicemia or skin and soft tissue infections have been relatively well reported. In total, the 1-month mortality rate was 68% (17/25), whereas the overall survival rate was 32% (8/25). In particular, among 16 cases with skin and soft tissue infections, 12 (75%) died within the first 4 days after admission, regardless of the administration of antimicrobial agents and/or lower limb amputation, indicating extremely poor short-term prognosis.
{"title":"Aeromonas Infections in Patients with Liver Cirrhosis in Japan","authors":"T. Shizuma","doi":"10.4172/2167-0889.1000235","DOIUrl":"https://doi.org/10.4172/2167-0889.1000235","url":null,"abstract":"Aeromonas species are recognized as opportunistic pathogens that cause serious problems in patients with liver cirrhosis (LC). In this article, 25 case reports of Aeromonas infections in patients with LC in Japan are reviewed and summarized. Among the 25 cases, cases of septicemia or skin and soft tissue infections have been relatively well reported. In total, the 1-month mortality rate was 68% (17/25), whereas the overall survival rate was 32% (8/25). In particular, among 16 cases with skin and soft tissue infections, 12 (75%) died within the first 4 days after admission, regardless of the administration of antimicrobial agents and/or lower limb amputation, indicating extremely poor short-term prognosis.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90296351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.35248/2167-0889.19.8.238
T. Shizuma
Although spontaneous peritonitis is a common infection in liver cirrhosis patients, little is known about the clinical characteristics and treatments of spontaneous fungal peritonitis (SFP) or fungiascites. Although diagnosis of SFP or fungiascites is made according to the cell counts and culture in ascitic fluid, delayed diagnosis has been associated with poor prognosis of SFP. Risk factors for SFP include severe underlying liver dysfunction, hospitalization and nosocomial infections. SFP mortality rates have been estimated as higher than those of spontaneous bacterial peritonitis. Although early administration of appropriate antifungal agents may be necessary, it remains uncertain whether antifungal therapies would decrease SFP’s mortality rate.
{"title":"Spontaneous Fungal Peritonitis in Patients with Liver Cirrhosis","authors":"T. Shizuma","doi":"10.35248/2167-0889.19.8.238","DOIUrl":"https://doi.org/10.35248/2167-0889.19.8.238","url":null,"abstract":"Although spontaneous peritonitis is a common infection in liver cirrhosis patients, little is known about the clinical characteristics and treatments of spontaneous fungal peritonitis (SFP) or fungiascites. Although diagnosis of SFP or fungiascites is made according to the cell counts and culture in ascitic fluid, delayed diagnosis has been associated with poor prognosis of SFP. Risk factors for SFP include severe underlying liver dysfunction, hospitalization and nosocomial infections. SFP mortality rates have been estimated as higher than those of spontaneous bacterial peritonitis. Although early administration of appropriate antifungal agents may be necessary, it remains uncertain whether antifungal therapies would decrease SFP’s mortality rate.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"1207 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79391111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-01-01DOI: 10.35248/2167-0889.19.8.237
N. Yılmaz, A. Balkan, M. Koruk
Background: In this study, it was aimed to evaluate the relationship between the severity of necroinflammation in the liver and the stage of fibrosis and the serum levels of Serum Prolidase Activity (SPA) and Cytokeratin (CK)-18 in patients with active Chronic Hepatitis B (CHB) and asymptomatic Hepatitis B Virus (HBV) carriers. Methods: Biochemical analyses, serological parameters associated with HBV and serum prolidase activity and CK-18 levels were measured in asymptomatic HBV carriers (n=65), active CHB patients (n=60) and healthy controls (n=27). Liver biopsies were performed on asymptomatic HBV carriers and active CHB patients. Findings: SPA level was significantly higher in active CHB patients (819.92 ± 123.74 IU/L) compared to asymptomatic HBV carriers (732.99 ± 124.70 IU/L) and was higher in asymptomatic HBV carriers compared to healthy controls (529.4 ± 74.73 IU/L) (p=0.001). The diagnostic cut-off value of SPA level was found 751.15 U/L. When this cut-off value was taken to differentiate HBe-Ag negative CHB in asymptomatic HBV carriers, sensitivity and specificity of efficacy were 72% and 63% respectively (c-statistics: 0.707). A strong positive correlation was observed between serum prolidase level and the severity of fibrosis in asymptomatic HBV carriers (r=0.603, p=0.000). A positive correlation was determined between SPA level and Histological Activity Index (HAI) scores in patients with active CHB and asymptomatic HBV carriers. The serum CK-18 levels were significantly lower in the healthy control group when compared to the asymptomatic HBV carriers and active CHB patients (p=0.001). Conclusion: Prolidase enzyme may be beneficial in differentiating asymptomatic HBV carriers from HBeAg-negative CHB patients when used in combination with ALT and HBV-DNA levels.
{"title":"Importance of Prolidase Enzyme Activity and Serum Cytokeratin 18 Levels for Differential Diagnosis between Asymptomatic Hepatitis B Carriers and HBeAg Negative Chronic Hepatitis B Patients","authors":"N. Yılmaz, A. Balkan, M. Koruk","doi":"10.35248/2167-0889.19.8.237","DOIUrl":"https://doi.org/10.35248/2167-0889.19.8.237","url":null,"abstract":"Background: In this study, it was aimed to evaluate the relationship between the severity of necroinflammation in the liver and the stage of fibrosis and the serum levels of Serum Prolidase Activity (SPA) and Cytokeratin (CK)-18 in patients with active Chronic Hepatitis B (CHB) and asymptomatic Hepatitis B Virus (HBV) carriers. Methods: Biochemical analyses, serological parameters associated with HBV and serum prolidase activity and CK-18 levels were measured in asymptomatic HBV carriers (n=65), active CHB patients (n=60) and healthy controls (n=27). Liver biopsies were performed on asymptomatic HBV carriers and active CHB patients. Findings: SPA level was significantly higher in active CHB patients (819.92 ± 123.74 IU/L) compared to asymptomatic HBV carriers (732.99 ± 124.70 IU/L) and was higher in asymptomatic HBV carriers compared to healthy controls (529.4 ± 74.73 IU/L) (p=0.001). The diagnostic cut-off value of SPA level was found 751.15 U/L. When this cut-off value was taken to differentiate HBe-Ag negative CHB in asymptomatic HBV carriers, sensitivity and specificity of efficacy were 72% and 63% respectively (c-statistics: 0.707). A strong positive correlation was observed between serum prolidase level and the severity of fibrosis in asymptomatic HBV carriers (r=0.603, p=0.000). A positive correlation was determined between SPA level and Histological Activity Index (HAI) scores in patients with active CHB and asymptomatic HBV carriers. The serum CK-18 levels were significantly lower in the healthy control group when compared to the asymptomatic HBV carriers and active CHB patients (p=0.001). Conclusion: Prolidase enzyme may be beneficial in differentiating asymptomatic HBV carriers from HBeAg-negative CHB patients when used in combination with ALT and HBV-DNA levels.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"57 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89732410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-03-02DOI: 10.4172/2167-0889.1000227
Huanle Yang, J. Xiang, Jian Dong, Jiwen Cheng, Xinglong Zheng, Peng Liu, Rongqian Wu, Y. Lv
Objectives: The knowledge on how static magnetic fields (SMF) of magnetic implants affect living cells and tissues is limited while these magnetic devices are more and more frequently adopted in certain surgical approaches. Methods: In this study, we exposed cultures of human gallbladder cancer cells to SMF continuously for up to 7 days, trying to simulate the exposure pattern of surgical magnetic implants, and implanted magnetic devices into tumor-bearing nude mice for 1 month, then evaluated the effect on proliferation and apoptosis of cancer cells and tissues. Results: It showed that after SMF exposure, whereas in vitro study showed decreased cell proliferation and increased apoptosis of the gallbladder cancer cells, in vivo study showed no significant differences both on proliferation and on apoptosis. Conclusions: Our findings indicate that with current magnetic biliary anastomosis devices, the SMF from magnetic implants shows little effects on proliferative and apoptotic activities of gallbladder cancer cells in vivo, while there are still possibilities that long-term continuous SMF exposure from surgical magnetic implants may interact with living cells, probably in a feeble manner.
{"title":"Effect of Static Magnetic Fields on Proliferation and Apoptosis of Gallbladder Cancer Cells: An in vitro and in vivo study","authors":"Huanle Yang, J. Xiang, Jian Dong, Jiwen Cheng, Xinglong Zheng, Peng Liu, Rongqian Wu, Y. Lv","doi":"10.4172/2167-0889.1000227","DOIUrl":"https://doi.org/10.4172/2167-0889.1000227","url":null,"abstract":"Objectives: The knowledge on how static magnetic fields (SMF) of magnetic implants affect living cells and tissues is limited while these magnetic devices are more and more frequently adopted in certain surgical approaches. \u0000Methods: In this study, we exposed cultures of human gallbladder cancer cells to SMF continuously for up to 7 days, trying to simulate the exposure pattern of surgical magnetic implants, and implanted magnetic devices into tumor-bearing nude mice for 1 month, then evaluated the effect on proliferation and apoptosis of cancer cells and tissues. \u0000Results: It showed that after SMF exposure, whereas in vitro study showed decreased cell proliferation and increased apoptosis of the gallbladder cancer cells, in vivo study showed no significant differences both on proliferation and on apoptosis. \u0000Conclusions: Our findings indicate that with current magnetic biliary anastomosis devices, the SMF from magnetic implants shows little effects on proliferative and apoptotic activities of gallbladder cancer cells in vivo, while there are still possibilities that long-term continuous SMF exposure from surgical magnetic implants may interact with living cells, probably in a feeble manner.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"3 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2018-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89322151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-05DOI: 10.4172/2167-0889.1000225
N. Gupta, M. Wadhawan, Varun Gupta
Tropical splenomegaly syndrome has rarely been associated as a cause of portal hypertension in patients living in endemic malarial zone. TSS has however has never been reported to be associated with portal vein thrombosis. We report a case of a 17 year old male who presented with features of portal hypertension and on radiological evaluation was found to have portal vein thrombus with cavernoma formation. Liver biopsy was performed for ruling out other pathologies and cirrhosis and was found to have hemozoin pigment along with features of inflow vascular pathology. We here in report first case of tropical splenomegaly with portal vein thrombosis.
{"title":"Portal Vein Thrombosis with Tropical Splenomegaly-A Rare Coincidental Finding","authors":"N. Gupta, M. Wadhawan, Varun Gupta","doi":"10.4172/2167-0889.1000225","DOIUrl":"https://doi.org/10.4172/2167-0889.1000225","url":null,"abstract":"Tropical splenomegaly syndrome has rarely been associated as a cause of portal hypertension in patients living in endemic malarial zone. TSS has however has never been reported to be associated with portal vein thrombosis. \u0000We report a case of a 17 year old male who presented with features of portal hypertension and on radiological evaluation was found to have portal vein thrombus with cavernoma formation. Liver biopsy was performed for ruling out other pathologies and cirrhosis and was found to have hemozoin pigment along with features of inflow vascular pathology. We here in report first case of tropical splenomegaly with portal vein thrombosis.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"50 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2018-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75619760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2018-01-01DOI: 10.4172/2167-0889.1000229
Ana Cláudia de Souza Silva, A. Andrade, Quelson Coelho Lisboa, C. X. Lima, J. Araújo, Thaís Gambogi, V. Borges, I. Filho
Ana Claudia De Souza Silva1, Antônio Márcio De Faria Andrade1, Quelson Coelho Lisboa1, Cristiano Xavier de Lima1, Juliana Papatella Araújo1, Thaís Ribeiro Gambogi1, Valdineria Oliveira Borges1 and Idiberto José Zotarelli Filho2* 1Department of gastroenterology, Hepatology and Liver Transplantation Felício Rocho Hospital, Belo Horizonte, MG, Brazil 2Post Graduate and Continuing Education (Unipos), Department of Scientific Production, Street Ipiranga, 3460, São José do Rio Preto SP, Brazil
Ana Claudia De Souza silva a1, Antônio Márcio De Faria Andrade1, Quelson Coelho Lisboa1, Cristiano Xavier De Lima1, Juliana Papatella Araújo1, Thaís Ribeiro Gambogi1, Valdineria Oliveira Borges1和Idiberto jos Zotarelli Filho2* 1巴西贝洛奥里藏特罗乔医院消化内科、肝脏内科和肝脏移植科Felício巴西罗乔医院2研究生和继续教育(Unipos)，科学生产部，Street Ipiranga, 3460， o jos do Rio Preto SP，巴西
{"title":"Epidemiologic Study on the Incidence of Biliary Complications after Liver Transplantation","authors":"Ana Cláudia de Souza Silva, A. Andrade, Quelson Coelho Lisboa, C. X. Lima, J. Araújo, Thaís Gambogi, V. Borges, I. Filho","doi":"10.4172/2167-0889.1000229","DOIUrl":"https://doi.org/10.4172/2167-0889.1000229","url":null,"abstract":"Ana Claudia De Souza Silva1, Antônio Márcio De Faria Andrade1, Quelson Coelho Lisboa1, Cristiano Xavier de Lima1, Juliana Papatella Araújo1, Thaís Ribeiro Gambogi1, Valdineria Oliveira Borges1 and Idiberto José Zotarelli Filho2* 1Department of gastroenterology, Hepatology and Liver Transplantation Felício Rocho Hospital, Belo Horizonte, MG, Brazil 2Post Graduate and Continuing Education (Unipos), Department of Scientific Production, Street Ipiranga, 3460, São José do Rio Preto SP, Brazil","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"17 8‐9","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91440340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：